Jeff Hall

While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.

Employing quantitative computed tomography, the staging system’s insights on stenosis, ischemia and coronary atherosclerosis may facilitate individualized assessments of heart disease risk.

Computed tomography (CT) findings from over 1,700 patients with stable chest pain reveal that coronary artery calcium (CAC) scores of 0 are associated with a 4.1 percent prevalence of obstructive coronary artery disease (CAD) whereas CAC scores of 400 or higher are linked to a 76.1 percent incidence of obstructive CAD, according to research from a multinational study.

In comparison to standard-dose lung CT, the combination of deep learning image reconstruction with ultra-low-dose CT offered similar detection and characterization of pulmonary nodules at a nearly 93 percent reduction of radiation dosing, according to new research.

A recent pediatric clinical trial revealed that left ventricular opacification with the ultrasound agent Definity improved ejection fraction assessment for 80 percent of patients.

Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.

In a study of nearly 2,500 women with BRCA1 or BRCA2 sequence variations, researchers found that MRI surveillance led to a 3.2 percent breast cancer mortality risk at 20 years in contrast to a 14.9 percent mortality risk for those who did not have MRI surveillance.

Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.

Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.

Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).

A new meta-analysis noted pooled sensitivity and specificity rates of 83 percent and 91 percent, respectively, for the use of non-contrast abbreviated MRI in surveillance of hepatocellular carcinoma (HCC).

Emphasizing upgraded angio suite capabilities as well as improved 2D and 3D imaging, Philips will unveil the Azurion Neuro Biplane System at the European Congress of Radiology.

Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.

For patients with suspected acute stroke, researchers noted higher image quality for deep learning-accelerated MRI, which can be completed over 11 minutes sooner than similar sequences for conventional MRI.

For people with COVID-19 related brain fog, emerging dynamic contrast-enhanced MRI (DCE-MRI) research findings revealed blood-brain barrier disruption in multiple brain regions, including temporal lobes and the frontal cortex, up to a year after active infection.

What does the current evidence reveal for four FDA-cleared AI software modalities for breast ultrasound? Leading researchers review the study findings in a recently published literature review.

Offering rapid automated segmentation of brain structures, the ClearPoint 2.2 software reportedly enhances visualization for a variety of targeted, MRI-guided procedures.

The use of computed tomography (CT) for cases of minor head trauma was associated with a 29 percent higher incidence of hematologic malignant neoplasms in comparison to those with no CT, according to a new study involving over 2,400,000 pediatric patients.

In comparison to biennial mammography screening between the ages of 50 to 74, researchers found that annual screening between 40 and 79 years of age resulted in a greater than 16 percent higher reduction in breast cancer mortality.

The use of ultrahigh spatial resolution with photon-counting CT led to lower Coronary Artery Disease Reporting and Data System (CAD-RADS) category assessments in over 54 percent of patients in comparison to the use of standard spatial resolution, according to recently published research.

Patients who had CT angiography procedures reported lower pain levels, better preparation and were 25 percent more willing to undergo the procedure again in comparison to patients who had invasive coronary angiography, according to newly published research.

Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.

For women with dense breasts, only 25 percent of breast radiologists are confident in the use of mammography for diagnosing invasive lobular carcinoma, according to newly published survey results from the Society of Breast Imaging.

In a recent assessment of PI-RADS upgrading rules, researchers found that ignoring the upgrading rules would lead to one missed diagnosis of clinically significant prostate cancer per 5.5 biopsies avoided with MRI-focused risk pathways.

Women with an increasing number of unmet social needs were 26 percent less likely to have mammography screening, according to a recent study of over 300 women with breast cancer.

The adjunctive use of AI software led to 16 percent and 10 percent increases in sensitivity rates for the detection of ARIA-E and ARIA-H, respectively, in patients with Alzheimer’s disease, according to newly published research.

In an analysis of repeat prostate cancer screening, researchers noted no suspicious MRI findings for over 86 percent of men who had PSA levels of 3 ng/mL or greater at a second prostate cancer screening.

The AI-enabled HealthFLD software demonstrated a 77.8 percent sensitivity rate and a 93.2 percent specificity rate for diagnosing moderate hepatic steatosis on contrast-enhanced CT scans in a recent study of over 2,900 patients.

In a recent interview, Vivianne Freitas, M.D., discussed new research findings on positron emission mammography (PEM), pertinent benefits of the technology and its potential as a viable alternative in the future to conventional imaging techniques for breast cancer screening.

Facilitating timely diagnosis and intervention for brain bleeds, the artificial intelligence (AI)-powered Viz ICH Plus software may provide quantified assessment for intracranial hyperdensities, lateral ventricles and midline shifts.